prof. dr. E. (Edo) Vellenga

Professor

prof. dr. E. (Edo) Vellenga
Telephone:
E-mail:
e.vellenga umcg.nl

Research

  1. de Boer, B. (2020). Unraveling clonal heterogeneity in acute myeloid leukemia. [Groningen]: Rijksuniversiteit Groningen. https://doi.org/10.33612/diss.113125010
  2. Folkerts, H. (2019). Autophagy in normal hematopoiesis and leukemia: Biological and therapeutic implications. [Groningen]: Rijksuniversiteit Groningen.
  3. Berger, G. (2019). Genetic defects in myeloid malignancies and preleukemic conditions. [Groningen]: Rijksuniversiteit Groningen.
  4. de Waal, E. G. M. (2018). Multiple aspects of a plasma cell dyscrasia. [Groningen]: Rijksuniversiteit Groningen.
  5. Hilgendorf, S. (2018). The long road: the autophagic network and TP53/ASXL1 aberrations in hematopoietic malignancies. [Groningen]: Rijksuniversiteit Groningen.
  6. Radulovic, V. (2014). The role of epigenetic modifiers in hematopoiesis. [S.l.]: [S.n.].
  7. Jonge-Peeters, S. D. P. W. M. D. (2011). ABC transporters and cholesterol metabolism in acute myeloid leukemia. [S.n.].
  8. Agool, A. (2011). PET and SPECT imaging of bone marrow disorders. [S.l.]: [s.n.].
  9. Weide, K. V. D. (2011). The use of statins in acute myeloid leukemia. Groningen: s.n.
  10. Wierenga, A. T. J. (2010). STAT3 and STAT5 signaling in normal and leukemic hematopoietic cells. Groningen: [s.n.].
  11. Hovenga, S. (2007). Clinical and biological aspects of multiple myeloma. [S.l.]: [s.n.].
  12. Louwes, H. (2002). Platelet kinetics in patients with thrombocytopenia. Groningen: s.n.
  13. Kolk, D. M. V. D. (2002). The role of drug effux pumps in acute myeloid leukemia. Groningen: s.n.

ID: 156947